ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,913.23
      -0.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      05/07/20204:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/07/20204:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/07/20204:03PMGlobeNewswire Inc.Adamas Reports First Quarter 2020 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/27/20204:03PMGlobeNewswire Inc.Adamas to Announce First Quarter 2020 Financial Results and Host Conference Call on May 7, 2020NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/23/20204:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/23/20204:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/10/20204:06PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/20/20206:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/19/20204:46PMPR Newswire (US)Adamas Pharmaceuticals Stock - Kehoe Law Firm, P.C. Investigating Breach of Fiduciary Duty Claims on Behalf of ADMS Investors...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/19/20204:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/19/20204:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/06/20204:39PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/25/20204:21PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/25/20204:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/25/20204:05PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/25/20204:03PMGlobeNewswire Inc.Adamas Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/20/20204:01PMGlobeNewswire Inc.Adamas to Present at Upcoming Healthcare ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/19/20204:02PMGlobeNewswire Inc.Adamas to Announce Fourth Quarter 2019 Financial Results and Host Conference Call on February 25, 2020NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/14/20205:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/14/20204:08PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/14/202012:31PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/13/20205:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/13/20204:17PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/13/202011:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/13/20209:00AMGlobeNewswire Inc.Adamas To Present Analysis of Clinical Trials on GOCOVRI® Treatment at the 3rd Pan American Parkinson’s Disease and Moveme...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/11/20204:15PMGlobeNewswire Inc.Adamas Announces Publication of the Two-Year Phase 3 Open-Label EASE LID 2 Trial of GOCOVRI® for Dyskinesia in Patients with...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      02/03/202010:11AMBusiness WireADMS INVESTOR DEADLINE IN 7 DAYS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/10/20204:30PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/09/20201:05AMPR Newswire (US)LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the FirmNASDAQ:ADMSAdamas Pharmaceuticals Inc
      01/08/20209:15AMGlobeNewswire Inc.Adamas Provides Preliminary Fourth Quarter and Full Year 2019 GOCOVRI® Product Sales and Outlines Key Priorities for 2020NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS